Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of Efficacy and Safety of Tonlamarsen in Participants With Acute Severe Hypertension Recently Discharged From the Hospital
Sponsor: Kardigan, Inc.
Summary
The purpose of this study is to evaluate the blood pressure-lowering effect of tonlamarsen in adult participants who were recently discharged from the hospital, after treatment for acute severe hypertension.
Official title: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Tonlamarsen in Participants With Acute Severe Hypertension Recently Discharged From the Hospital
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2026-04-20
Completion Date
2027-02-23
Last Updated
2026-04-06
Healthy Volunteers
No
Conditions
Interventions
Tonlamarsen
Tonlamarsen will be administered subcutaneously (under the skin) every 4 weeks during the randomized part of the study
Placebo
Placebo will be administered subcutaneously (under the skin) every 4 weeks during the randomized part of the study
Locations (1)
Progressive Medical Research
Port Orange, Florida, United States